Propranolol Trial for Aggression and Self-Injury in People with Autism
Phase 2
60
about 3.1 years
12–40
2 sites in NY
About this study
This trial is testing if propranolol can help reduce aggression, self-injury, and severe disruptive behaviors in people with autism. Participants will receive either propranolol or a placebo daily for 12 weeks. After the initial period, some participants may continue receiving propranolol for another 12 weeks.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Propranolol
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
propranolol (Non-selective beta blocker; slows heart rate)
Primary: Incidence of safety concerns and side effects associated with high-dose propranolol, including changes in blood pressure, pulse, and occurrence of dysrhythmias.
Psychiatry / Mental Health